Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal bleeding (HP:0001892)help
Grandparent Node:
expand
Vascular skin abnormality (HP:0011276)help
Parent Node:
expand
Subcutaneous hemorrhage (HP:0001933)help
..Starting node
..expand
Purpura (HP:0000979)help
Term ID: 979
Name: Purpura
Synonym: Blood spots; Red or purple spots on the skin
Definition: Purpura (from Latin: purpura, meaning "purple") is the appearance of red or purple discolorations on the skin that do not blanch on applying pressure. They are caused by bleeding underneath the skin. This term refers to an abnormally increased susceptibility to developing purpura. Purpura are larger than petechiae.
Comments:
Reference: HP:0000979
Genes and Diseases:
 
       Child Nodes:
........expandPalpable purpura (HP:0031363) help
........expandMacular purpura (HP:0031365) help
................... HP:0000967 Petechiae
................... HP:0031364 Ecchymosis

 Sister Nodes: 
..expandBruising susceptibility (HP:0000978) help
..expandSpontaneous hematomas (HP:0007420) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000979HP:0000979Purpura0ACP5 CL E G H54124OMIM:607944Spondyloenchondrodysplasia with immune dysregulation.16
HP:0000979HP:0000979Purpura0ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0000979HP:0000979Purpura0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0000979HP:0000979Purpura0APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0000979HP:0000979Purpura0ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040283 - Occasional1
HP:0000979HP:0000979Purpura0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional1
HP:0000979HP:0000979Purpura0ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0000979HP:0000979Purpura0BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0000979HP:0000979Purpura0BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0000979HP:0000979Purpura0C2 CL E G H7171248OMIM:217000Complement component 2 deficiency.23
HP:0000979HP:0000979Purpura0C4A CL E G H7201323OMIM:614380Complement component 4A deficiency.1
HP:0000979HP:0000979Purpura0CALR CL E G H8111455OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included1
HP:0000979HP:0000979Purpura0CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0000979HP:0000979Purpura0CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0000979HP:0000979Purpura0CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent
HP:0000979HP:0000979Purpura0CD19 CL E G H9301633ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent38
HP:0000979HP:0000979Purpura0CD81 CL E G H9751701ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0000979HP:0000979Purpura0CD81 CL E G H9751701OMIM:613496Immunodeficiency, common variable, 61
HP:0000979HP:0000979Purpura0CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0000979HP:0000979Purpura0CFH CL E G H30754883OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.86
HP:0000979HP:0000979Purpura0CFHR1 CL E G H30784888OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0000979HP:0000979Purpura0CFHR3 CL E G H1087816980OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0000979HP:0000979Purpura0CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 127
HP:0000979HP:0000979Purpura0CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4102
HP:0000979HP:0000979Purpura0COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndrome373
HP:0000979HP:0000979Purpura0COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0000979HP:0000979Purpura0COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndrome660
HP:0000979HP:0000979Purpura0COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndrome325
HP:0000979HP:0000979Purpura0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional6
HP:0000979HP:0000979Purpura0CR2 CL E G H13802336ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0000979HP:0000979Purpura0CTLA4 CL E G H14932505ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional10
HP:0000979HP:0000979Purpura0ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic42
HP:0000979HP:0000979Purpura0ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathy42
HP:0000979HP:0000979Purpura0ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 513
HP:0000979HP:0000979Purpura0F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiency60
HP:0000979HP:0000979Purpura0F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of60
HP:0000979HP:0000979Purpura0F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiency32
HP:0000979HP:0000979Purpura0F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency32
HP:0000979HP:0000979Purpura0F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency44
HP:0000979HP:0000979Purpura0FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopeniaHP:0040282 - Frequent
HP:0000979HP:0000979Purpura0FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III23
HP:0000979HP:0000979Purpura0FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000979HP:0000979Purpura0FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0000979HP:0000979Purpura0GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked29
HP:0000979HP:0000979Purpura0GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia29
HP:0000979HP:0000979Purpura0GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal.
HP:0000979HP:0000979Purpura0GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
HP:0000979HP:0000979Purpura0GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0000979HP:0000979Purpura0GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1129
HP:0000979HP:0000979Purpura0GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0000979HP:0000979Purpura0GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040283 - Occasional16
HP:0000979HP:0000979Purpura0GNA14 CL E G H96304382ORPHA:1063Tufted angiomaHP:0040283 - Occasional
HP:0000979HP:0000979Purpura0GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0000979HP:0000979Purpura0GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant23
HP:0000979HP:0000979Purpura0GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0000979HP:0000979Purpura0GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent23
HP:0000979HP:0000979Purpura0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional8
HP:0000979HP:0000979Purpura0GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0000979HP:0000979Purpura0GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0000979HP:0000979Purpura0GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent8
HP:0000979HP:0000979Purpura0GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 1124
HP:0000979HP:0000979Purpura0GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0000979HP:0000979Purpura0GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0000979HP:0000979Purpura0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional3
HP:0000979HP:0000979Purpura0HLA-DPA1 CL E G H31134938ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional
HP:0000979HP:0000979Purpura0HLA-DPB1 CL E G H31154940ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional1
HP:0000979HP:0000979Purpura0HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia.3
HP:0000979HP:0000979Purpura0HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0000979HP:0000979Purpura0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0000979HP:0000979Purpura0ICOS CL E G H298515351ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0000979HP:0000979Purpura0IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemia23
HP:0000979HP:0000979Purpura0IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000979HP:0000979Purpura0IRF2BP2 CL E G H35994821729ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent4
HP:0000979HP:0000979Purpura0ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent119
HP:0000979HP:0000979Purpura0ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 1669
HP:0000979HP:0000979Purpura0ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent69
HP:0000979HP:0000979Purpura0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0000979HP:0000979Purpura0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0000979HP:0000979Purpura0ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent80
HP:0000979HP:0000979Purpura0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0000979HP:0000979Purpura0JAK2 CL E G H37176192OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included57
HP:0000979HP:0000979Purpura0JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0000979HP:0000979Purpura0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional2
HP:0000979HP:0000979Purpura0LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0000979HP:0000979Purpura0MPL CL E G H43527217OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included97
HP:0000979HP:0000979Purpura0MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0000979HP:0000979Purpura0MS4A1 CL E G H9317315ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0000979HP:0000979Purpura0MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic feverHP:0040283 - Occasional150
HP:0000979HP:0000979Purpura0MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemiaHP:0040283 - Occasional9
HP:0000979HP:0000979Purpura0NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000979HP:0000979Purpura0NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0000979HP:0000979Purpura0NFKB1 CL E G H47907794ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent7
HP:0000979HP:0000979Purpura0NFKB2 CL E G H47917795ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent11
HP:0000979HP:0000979Purpura0NLRP3 CL E G H11454816400ORPHA:1451CINCA syndromeHP:0040283 - Occasional217
HP:0000979HP:0000979Purpura0NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000979HP:0000979Purpura0NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0000979HP:0000979Purpura0NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000979HP:0000979Purpura0OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria23
HP:0000979HP:0000979Purpura0ORAI1 CL E G H8487625896ORPHA:3204Stormorken-Sjaastad-Langslet syndromeHP:0040281 - Very frequent19
HP:0000979HP:0000979Purpura0P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0000979HP:0000979Purpura0PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0000979HP:0000979Purpura0PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0000979HP:0000979Purpura0PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0000979HP:0000979Purpura0PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemia58
HP:0000979HP:0000979Purpura0PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0000979HP:0000979Purpura0PRKCD CL E G H55809399ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0000979HP:0000979Purpura0PROC CL E G H56249451ORPHA:745Severe hereditary thrombophilia due to congenital protein C deficiencyHP:0040282 - Frequent65
HP:0000979HP:0000979Purpura0PROC CL E G H56249451OMIM:612304Thrombophilia due to protein C deficiency, autosomal recessive.65
HP:0000979HP:0000979Purpura0PROS1 CL E G H56279456ORPHA:743Severe hereditary thrombophilia due to congenital protein S deficiencyHP:0040281 - Very frequent75
HP:0000979HP:0000979Purpura0PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive.75
HP:0000979HP:0000979Purpura0PROS1 CL E G H56279456OMIM:612336Thrombophilia, hereditary, due to protein S deficiency, autosomal.75
HP:0000979HP:0000979Purpura0PRTN3 CL E G H56579495ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional
HP:0000979HP:0000979Purpura0PTPN22 CL E G H261919652ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional3
HP:0000979HP:0000979Purpura0RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 267
HP:0000979HP:0000979Purpura0RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0000979HP:0000979Purpura0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0000979HP:0000979Purpura0SAMD9 CL E G H548091348OMIM:617053Mirage syndrome8
HP:0000979HP:0000979Purpura0SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemia26
HP:0000979HP:0000979Purpura0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0000979HP:0000979Purpura0SH2B3 CL E G H1001929605OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included4
HP:0000979HP:0000979Purpura0STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0000979HP:0000979Purpura0STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000979HP:0000979Purpura0STIM1 CL E G H678611386ORPHA:3204Stormorken-Sjaastad-Langslet syndromeHP:0040281 - Very frequent31
HP:0000979HP:0000979Purpura0STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0000979HP:0000979Purpura0STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0000979HP:0000979Purpura0TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0000979HP:0000979Purpura0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional32
HP:0000979HP:0000979Purpura0TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0000979HP:0000979Purpura0TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemia48
HP:0000979HP:0000979Purpura0TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemia238
HP:0000979HP:0000979Purpura0TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0000979HP:0000979Purpura0TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 3.67
HP:0000979HP:0000979Purpura0TNFRSF13B CL E G H2349518153ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0000979HP:0000979Purpura0TNFRSF13C CL E G H11565017755ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent12
HP:0000979HP:0000979Purpura0TNFSF12 CL E G H874211927ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0000979HP:0000979Purpura0TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0000979HP:0000979Purpura0TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 1.56
HP:0000979HP:0000979Purpura0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0000979HP:0000979Purpura0UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0000979HP:0000979Purpura0USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 22
HP:0000979HP:0000979Purpura0USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0000979HP:0000979Purpura0USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0000979HP:0000979Purpura0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0000979HP:0000979Purpura0WAS CL E G H745412731OMIM:313900Thrombocytopenia 165
HP:0000979HP:0000979Purpura0WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent65
HP:0000979HP:0000979Purpura0WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome.65
HP:0000979HP:0000979Purpura0WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent6
HP:0000979HP:0000979Purpura0ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1
HP:0000979HP:0031363Palpable purpura1 CL E G H
HP:0000979HP:0031365Macular purpura1AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic95
HP:0000979HP:0031365Macular purpura1APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0000979HP:0031365Macular purpura1ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0000979HP:0031365Macular purpura1BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemia101
HP:0000979HP:0031365Macular purpura1BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0000979HP:0031365Macular purpura1CALR CL E G H8111455ORPHA:824Primary myelofibrosis1
HP:0000979HP:0031365Macular purpura1CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0000979HP:0031365Macular purpura1CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopenia
HP:0000979HP:0031365Macular purpura1CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0000979HP:0031365Macular purpura1CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 127
HP:0000979HP:0031365Macular purpura1CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4102
HP:0000979HP:0031365Macular purpura1COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndrome373
HP:0000979HP:0031365Macular purpura1COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0000979HP:0031365Macular purpura1COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndrome660
HP:0000979HP:0031365Macular purpura1COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndrome325
HP:0000979HP:0031365Macular purpura1ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic42
HP:0000979HP:0031365Macular purpura1ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathy42
HP:0000979HP:0031365Macular purpura1ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 513
HP:0000979HP:0031365Macular purpura1F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiency60
HP:0000979HP:0031365Macular purpura1F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of60
HP:0000979HP:0031365Macular purpura1F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiency32
HP:0000979HP:0031365Macular purpura1F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency32
HP:0000979HP:0031365Macular purpura1F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency44
HP:0000979HP:0031365Macular purpura1FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopenia
HP:0000979HP:0031365Macular purpura1FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III23
HP:0000979HP:0031365Macular purpura1FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemia4
HP:0000979HP:0031365Macular purpura1FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0000979HP:0031365Macular purpura1GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked29
HP:0000979HP:0031365Macular purpura1GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia29
HP:0000979HP:0031365Macular purpura1GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal
HP:0000979HP:0031365Macular purpura1GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
HP:0000979HP:0031365Macular purpura1GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0000979HP:0031365Macular purpura1GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1129
HP:0000979HP:0031365Macular purpura1GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0000979HP:0031365Macular purpura1GNA14 CL E G H96304382ORPHA:1063Tufted angioma
HP:0000979HP:0031365Macular purpura1GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0000979HP:0031365Macular purpura1GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant23
HP:0000979HP:0031365Macular purpura1GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopenia23
HP:0000979HP:0031365Macular purpura1GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0000979HP:0031365Macular purpura1GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopenia8
HP:0000979HP:0031365Macular purpura1GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 1124
HP:0000979HP:0031365Macular purpura1GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0000979HP:0031365Macular purpura1HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia3
HP:0000979HP:0031365Macular purpura1HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0000979HP:0031365Macular purpura1HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0000979HP:0031365Macular purpura1IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemia23
HP:0000979HP:0031365Macular purpura1IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemia4
HP:0000979HP:0031365Macular purpura1ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopenia119
HP:0000979HP:0031365Macular purpura1ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 1669
HP:0000979HP:0031365Macular purpura1ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopenia69
HP:0000979HP:0031365Macular purpura1ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombasthenia69
HP:0000979HP:0031365Macular purpura1ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0000979HP:0031365Macular purpura1ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopenia80
HP:0000979HP:0031365Macular purpura1ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombasthenia80
HP:0000979HP:0031365Macular purpura1JAK2 CL E G H37176192ORPHA:824Primary myelofibrosis57
HP:0000979HP:0031365Macular purpura1LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0000979HP:0031365Macular purpura1MPL CL E G H43527217ORPHA:824Primary myelofibrosis97
HP:0000979HP:0031365Macular purpura1NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemia
HP:0000979HP:0031365Macular purpura1NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0000979HP:0031365Macular purpura1NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemia12
HP:0000979HP:0031365Macular purpura1NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0000979HP:0031365Macular purpura1NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemia
HP:0000979HP:0031365Macular purpura1OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria23
HP:0000979HP:0031365Macular purpura1P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0000979HP:0031365Macular purpura1PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0000979HP:0031365Macular purpura1PML CL E G H53719113ORPHA:520Acute promyelocytic leukemia3
HP:0000979HP:0031365Macular purpura1PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosis58
HP:0000979HP:0031365Macular purpura1PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemia58
HP:0000979HP:0031365Macular purpura1PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemia134
HP:0000979HP:0031365Macular purpura1RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 267
HP:0000979HP:0031365Macular purpura1RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemia2
HP:0000979HP:0031365Macular purpura1SAMD9 CL E G H548091348OMIM:617053Mirage syndrome8
HP:0000979HP:0031365Macular purpura1SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemia26
HP:0000979HP:0031365Macular purpura1STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemia110
HP:0000979HP:0031365Macular purpura1STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemia12
HP:0000979HP:0031365Macular purpura1STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosis85
HP:0000979HP:0031365Macular purpura1STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosis70
HP:0000979HP:0031365Macular purpura1TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemia22
HP:0000979HP:0031365Macular purpura1TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0000979HP:0031365Macular purpura1TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemia48
HP:0000979HP:0031365Macular purpura1TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemia238
HP:0000979HP:0031365Macular purpura1TET2 CL E G H5479025941ORPHA:824Primary myelofibrosis3
HP:0000979HP:0031365Macular purpura1TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0000979HP:0031365Macular purpura1TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0000979HP:0031365Macular purpura1UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosis116
HP:0000979HP:0031365Macular purpura1USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 22
HP:0000979HP:0031365Macular purpura1USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0000979HP:0031365Macular purpura1USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0000979HP:0031365Macular purpura1USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic7
HP:0000979HP:0031365Macular purpura1WAS CL E G H745412731OMIM:313900Thrombocytopenia 165
HP:0000979HP:0031365Macular purpura1WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome65
HP:0000979HP:0031365Macular purpura1WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndrome65
HP:0000979HP:0031365Macular purpura1WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndrome6
HP:0000979HP:0031365Macular purpura1ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemia1
HP:0000979HP:0031364Ecchymosis2AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0000979HP:0000967Petechiae2APOE CL E G H348613ORPHA:158029Sea-blue histiocytosisHP:0040281 - Very frequent39
HP:0000979HP:0031364Ecchymosis2ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0000979HP:0031364Ecchymosis2BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0000979HP:0000967Petechiae2BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0000979HP:0031364Ecchymosis2BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0000979HP:0031364Ecchymosis2CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0000979HP:0000967Petechiae2CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0000979HP:0000967Petechiae2CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0000979HP:0000967Petechiae2CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent
HP:0000979HP:0031364Ecchymosis2CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional
HP:0000979HP:0031364Ecchymosis2CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0000979HP:0031364Ecchymosis2CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 1.27
HP:0000979HP:0000967Petechiae2CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4.102
HP:0000979HP:0031364Ecchymosis2COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional373
HP:0000979HP:0031364Ecchymosis2COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0000979HP:0031364Ecchymosis2COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional660
HP:0000979HP:0031364Ecchymosis2COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional325
HP:0000979HP:0000967Petechiae2ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic.42
HP:0000979HP:0000967Petechiae2ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathyHP:0040282 - Frequent42
HP:0000979HP:0000967Petechiae2ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 5.13
HP:0000979HP:0031364Ecchymosis2F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional60
HP:0000979HP:0031364Ecchymosis2F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of.60
HP:0000979HP:0031364Ecchymosis2F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional32
HP:0000979HP:0031364Ecchymosis2F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency.32
HP:0000979HP:0031364Ecchymosis2F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0000979HP:0000967Petechiae2FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopeniaHP:0040282 - Frequent
HP:0000979HP:0000967Petechiae2FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III.23
HP:0000979HP:0031364Ecchymosis2FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000979HP:0000967Petechiae2FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000979HP:0000967Petechiae2FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0000979HP:0000967Petechiae2GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked.29
HP:0000979HP:0000967Petechiae2GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia.29
HP:0000979HP:0000967Petechiae2GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal.
HP:0000979HP:0031364Ecchymosis2GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeHP:0040284 - Very rare
HP:0000979HP:0000967Petechiae2GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0000979HP:0031364Ecchymosis2GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0000979HP:0031364Ecchymosis2GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1.129
HP:0000979HP:0000967Petechiae2GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0000979HP:0031364Ecchymosis2GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0000979HP:0000967Petechiae2GNA14 CL E G H96304382ORPHA:1063Tufted angiomaHP:0040283 - Occasional
HP:0000979HP:0000967Petechiae2GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent23
HP:0000979HP:0000967Petechiae2GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0000979HP:0031364Ecchymosis2GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0000979HP:0000967Petechiae2GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent23
HP:0000979HP:0031364Ecchymosis2GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional23
HP:0000979HP:0000967Petechiae2GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent8
HP:0000979HP:0031364Ecchymosis2GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional8
HP:0000979HP:0000967Petechiae2GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent8
HP:0000979HP:0031364Ecchymosis2GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0000979HP:0000967Petechiae2GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent21
HP:0000979HP:0000967Petechiae2HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia.3
HP:0000979HP:0031364Ecchymosis2HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0000979HP:0031364Ecchymosis2HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0000979HP:0031364Ecchymosis2IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional23
HP:0000979HP:0000967Petechiae2IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000979HP:0031364Ecchymosis2IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0000979HP:0031364Ecchymosis2ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional119
HP:0000979HP:0000967Petechiae2ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent119
HP:0000979HP:0000967Petechiae2ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 16.69
HP:0000979HP:0031364Ecchymosis2ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional69
HP:0000979HP:0000967Petechiae2ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent69
HP:0000979HP:0031364Ecchymosis2ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0000979HP:0031364Ecchymosis2ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0000979HP:0031364Ecchymosis2ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional80
HP:0000979HP:0000967Petechiae2ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent80
HP:0000979HP:0031364Ecchymosis2ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0000979HP:0000967Petechiae2JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0000979HP:0031364Ecchymosis2JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0000979HP:0000967Petechiae2LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0000979HP:0000967Petechiae2MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0000979HP:0031364Ecchymosis2MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0000979HP:0031364Ecchymosis2NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000979HP:0000967Petechiae2NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000979HP:0000967Petechiae2NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 2HP:0040283 - Occasional43
HP:0000979HP:0000967Petechiae2NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000979HP:0031364Ecchymosis2NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000979HP:0031364Ecchymosis2NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0000979HP:0000967Petechiae2NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000979HP:0031364Ecchymosis2NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0000979HP:0000967Petechiae2OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria.23
HP:0000979HP:0031364Ecchymosis2P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 8.5
HP:0000979HP:0000967Petechiae2PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0000979HP:0000967Petechiae2PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0000979HP:0031364Ecchymosis2PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0000979HP:0031364Ecchymosis2PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0000979HP:0000967Petechiae2PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0000979HP:0031364Ecchymosis2PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional58
HP:0000979HP:0000967Petechiae2PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0000979HP:0031364Ecchymosis2PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0000979HP:0000967Petechiae2RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 2HP:0040283 - Occasional67
HP:0000979HP:0031364Ecchymosis2RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0000979HP:0000967Petechiae2RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0000979HP:0000967Petechiae2SAMD9 CL E G H548091348OMIM:617053Mirage syndrome.8
HP:0000979HP:0031364Ecchymosis2SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional26
HP:0000979HP:0031364Ecchymosis2STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0000979HP:0000967Petechiae2STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0000979HP:0000967Petechiae2STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000979HP:0031364Ecchymosis2STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0000979HP:0000967Petechiae2STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0000979HP:0031364Ecchymosis2STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0000979HP:0031364Ecchymosis2STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0000979HP:0000967Petechiae2STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0000979HP:0000967Petechiae2TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0000979HP:0031364Ecchymosis2TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0000979HP:0031364Ecchymosis2TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0000979HP:0031364Ecchymosis2TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional48
HP:0000979HP:0031364Ecchymosis2TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional238
HP:0000979HP:0000967Petechiae2TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0000979HP:0031364Ecchymosis2TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0000979HP:0031364Ecchymosis2TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0000979HP:0000967Petechiae2TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0000979HP:0000967Petechiae2UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0000979HP:0031364Ecchymosis2UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0000979HP:0000967Petechiae2USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 2.2
HP:0000979HP:0031364Ecchymosis2USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0000979HP:0031364Ecchymosis2USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0000979HP:0031364Ecchymosis2USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0000979HP:0000967Petechiae2WAS CL E G H745412731OMIM:313900Thrombocytopenia 1.65
HP:0000979HP:0000967Petechiae2WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent65
HP:0000979HP:0000967Petechiae2WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome.65
HP:0000979HP:0000967Petechiae2WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent6
HP:0000979HP:0031364Ecchymosis2ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1
HP:0000979HP:0000967Petechiae2ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1


Genes (120) :ACP5 ADA2 AIP APOE ARL6IP6 ARVCF ATRX BCOR BRAF C2 C4A CALR CASP10 CD109 CD19 CD81 CDH23 CFH CFHR1 CFHR3 CHST14 CLCN7 COL1A1 COL3A1 COL5A1 COL5A2 COMT CR2 CTLA4 ETHE1 ETV6 F13A1 F13B F2 FCGR2C FERMT3 FIP1L1 FYB1 GATA1 GBA1 GFI1B GGCX GIMAP5 GNA11 GNA14 GP1BA GP1BB GP6 GP9 HIRA HLA-DPA1 HLA-DPB1 HOXA11 HPS1 HPS6 ICOS IFNG IRF2BP2 ITGA2 ITGA2B ITGB3 JAK2 JMJD1C LCP2 MPL MS4A1 MVK MYD88 NABP1 NEU1 NFKB1 NFKB2 NLRP3 NPM1 NR3C1 NUMA1 OCLN ORAI1 P2RY12 PEPD PML PRF1 PRKAR1A PRKCD PROC PROS1 PRTN3 PTPN22 RAB27A RARA RREB1 SAMD9 SBDS SEC24C SH2B3 STAT3 STAT5B STIM1 STX11 STXBP2 TBL1XR1 TBX1 TBXA2R TERC TERT TET2 TFR2 TNFRSF13B TNFRSF13C TNFSF12 TP53 TREX1 UFD1 UNC13D USP18 USP48 USP8 WAS WIPF1 ZBTB16

Diseases (75) :OMIM:607944 OMIM:615688 OMIM:219090 ORPHA:158029 ORPHA:1556 ORPHA:567 ORPHA:96253 ORPHA:520 OMIM:217000 OMIM:614380 OMIM:254450 ORPHA:824 OMIM:603909 ORPHA:853 ORPHA:1572 OMIM:613496 OMIM:235400 OMIM:601776 OMIM:611490 ORPHA:287 OMIM:130050 ORPHA:900 OMIM:602473 ORPHA:51188 OMIM:616216 ORPHA:331 OMIM:613225 OMIM:613235 OMIM:613679 ORPHA:3002 OMIM:612840 OMIM:273900 OMIM:314050 OMIM:300367 OMIM:608013 ORPHA:2072 OMIM:187900 OMIM:277450 OMIM:619463 ORPHA:1063 ORPHA:274 OMIM:153670 OMIM:231200 OMIM:614201 OMIM:605432 OMIM:203300 OMIM:614075 ORPHA:88 OMIM:187800 OMIM:273800 ORPHA:849 OMIM:619374 ORPHA:343 ORPHA:33226 ORPHA:93400 ORPHA:1451 OMIM:251290 ORPHA:3204 OMIM:609821 OMIM:170100 ORPHA:540 ORPHA:745 OMIM:612304 ORPHA:743 OMIM:614514 OMIM:612336 ORPHA:79477 OMIM:617053 OMIM:614009 OMIM:604250 OMIM:225750 OMIM:617397 OMIM:313900 ORPHA:906 OMIM:301000
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.